| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 04/02/2003 | EP1297129A2 Card domain containing polypeptides, encoding nucleic acids, and methods of use |
| 04/02/2003 | EP1297116A2 Method for isolating and purifying a protein and resulting protein |
| 04/02/2003 | EP1297014A2 Transporters and ion channels |
| 04/02/2003 | EP1297007A2 Mammalian protein phosphatases |
| 04/02/2003 | EP1296998A2 Hcv variants |
| 04/02/2003 | EP1296996A1 Purine derivatives |
| 04/02/2003 | EP1296990A2 Dihydropyridine compounds for the inhibition of calcium-influx |
| 04/02/2003 | EP1296987A1 Compounds for treating impaired fundic relaxation |
| 04/02/2003 | EP1296976A1 Novel 1,3-dihydro-2h-indol-one derivatives, method for preparing same and pharmaceutical compositions containing them |
| 04/02/2003 | EP1296972A1 Arylmethylamine derivatives for use as tryptase inhibitors |
| 04/02/2003 | EP1296961A1 1,4-diazepan-2,5-dione derivatives and their use as nk-1 receptor antagonists |
| 04/02/2003 | EP1296959A1 Methods and compositions utilizing quinazolinones |
| 04/02/2003 | EP1296951A1 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl- [2,3']bipyridinyl in pure crystalline form and process for synthesis |
| 04/02/2003 | EP1296949A2 Piperidine amides as modulators of chemokine receptor activity |
| 04/02/2003 | EP1296946A1 Aminothiolester compounds, pharmaceutical and cosmetic compositions containing same and uses thereof |
| 04/02/2003 | EP1296943A1 Amino acid derivatives and their use as medicines |
| 04/02/2003 | EP1296929A2 Modified forms of pharmacologically active agents and uses therefor |
| 04/02/2003 | EP1296709A1 Solubilised protein vaccines |
| 04/02/2003 | EP1296693A1 Immunotherapy or treating bacterial or viral infection at mucosal surfaces with probiotics, and compositions therefor. |
| 04/02/2003 | EP1296692A1 Use of a formulation made of or containing at least one dissimilated milk serum |
| 04/02/2003 | EP1296684A2 Treatment of gastroesophageal reflux disease using piperidine derivatives |
| 04/02/2003 | EP1296670A1 Therapeutic combinations of fatty acids |
| 04/02/2003 | EP1296650A2 Methods and compositions for treating pain of the mucous membrane |
| 04/02/2003 | EP1296644A2 Systems and methods for treating a mucosal surface |
| 04/02/2003 | EP1296636A1 USE OF EXOGENOUS LACTIC BACTERIA STRAIN AGAINST i ACTINOMYCES NAESLUNDII /i RELATED DISEASES |
| 04/02/2003 | EP1296552A2 Erk-5 deficient animals and methods of inhibiting angiogenesis through the inhibition of erk-5 |
| 04/02/2003 | EP1226143B1 Imidazopyridine derivatives used as phosphodiesterase vii inhibitors |
| 04/02/2003 | EP1208100B1 Selective antagonists of a2b adenosine receptors |
| 04/02/2003 | EP1165087A4 In vivo stain compounds and methods of use to identify dysplastic tissue |
| 04/02/2003 | EP1124841B1 Substituted phenyl alkenoyl guanidines, method for the production thereof, use thereof as medicaments or diagnostic agents and medicaments that contain them |
| 04/02/2003 | EP1114051B1 INHIBITORS OF p38 |
| 04/02/2003 | EP1021456B1 Macrocyclic 13-membered ring derivatives of erythromycins a and b |
| 04/02/2003 | EP0954519B1 Alpha-9 integrin antagonists and anti-inflammatory compositions therof |
| 04/02/2003 | EP0910348B1 Locally administrable, biodegradable and sustained-release pharmaceutical composition for periodontitis and process for preparation thereof |
| 04/02/2003 | EP0858326B1 Non-aqueous colonic purgative formulations |
| 04/02/2003 | EP0770081B1 Heterocycle-condensed morphinoid derivatives |
| 04/02/2003 | CN1407985A Heterocyclic dihydropyrimidine as potassium path inhibitor |
| 04/02/2003 | CN1407984A 1,8-naphthyridin-2 (1H)-one derivatives |
| 04/02/2003 | CN1407980A Heterocyclic derivatives |
| 04/02/2003 | CN1407972A 4-pyrimidine-N-acyl-L-phenylalanines |
| 04/02/2003 | CN1407971A Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof |
| 04/02/2003 | CN1407970A Urea compounds having muscarinic receptor antagonist activity |
| 04/02/2003 | CN1407894A Pharmaceutical composition |
| 04/02/2003 | CN1407891A Pharmaceutical composition for treatment and prevention of liver fibrosis and cirrhosis |
| 04/02/2003 | CN1407887A Oral liquid compositions |
| 04/02/2003 | CN1407857A 低聚糖混合物 Oligosaccharide mixture |
| 04/02/2003 | CN1407853A Device and method for performing biological modification of fluid |
| 04/02/2003 | CN1406940A Chlorophyll chromium and preparation and use thereof |
| 04/02/2003 | CN1406937A 1-[1-(hetero) aryl-1-perhydroxyalkylmethyl]-piperazine compound, preparation thereof and pharmaceutics containing it |
| 04/02/2003 | CN1406625A Oral liquid |
| 04/02/2003 | CN1406623A Levulose absorption retardant, compound, food and levulose absorption repressor |
| 04/02/2003 | CN1406620A Patent Chinese medicine and preparing process for deficiency syndrome |
| 04/02/2003 | CN1406603A Weizhen powder for gastrosia |
| 04/02/2003 | CN1406598A Oral cavity ulcer powder and preparation thereof |
| 04/02/2003 | CN1406593A Medicine |
| 04/02/2003 | CN1406589A Insect health-care products for liver and stomach and preparation thereof |
| 04/02/2003 | CN1104432C Pyrrole triazines and pyrimidine compound |
| 04/02/2003 | CN1104422C Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists |
| 04/02/2003 | CN1104418C Benzoheterocyclic derivatives |
| 04/02/2003 | CN1104412C Benzamidine derivatives and use thereof as medicaments with LTB4-antagonistic effect |
| 04/02/2003 | CN1104248C Chinese medicine for treating tuberculosis and hepatitis |
| 04/02/2003 | CN1104237C Use of omega-3 polyunsaturated acids |
| 04/02/2003 | CN1104236C 一种治疗胃病的口服液 A treatment for stomach oral |
| 04/02/2003 | CN1104229C Material intended to remineralise organomineral tissues |
| 04/02/2003 | CA2424540A1 Propionic acid derivatives with ppar-alpha activating properties |
| 04/01/2003 | US6541670 Antiinflammatory agents |
| 04/01/2003 | US6541638 (2S,4S)-1-(4-Mercapto-1-(naphthalene-2-sulfonyl)-pyrrolidine-2 -carbonyl)-piperidine-4-carboxylic acid ethyl ester for example; zinc protease inhibitors; for treating diseases associated with vasoconstriction |
| 04/01/2003 | US6541623 Sepsis shock therapy; rheumatic diseases; antiinflammatory agents; nucleotide sequence detector |
| 04/01/2003 | US6541605 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases |
| 04/01/2003 | US6541493 Type A, B, C and D crystals of said compound; excellent in stability, and has advantages in handling, storage, and pharmaceutical preparation. |
| 04/01/2003 | US6541490 Treating ischemia or reoxygenation injury; preparation from a bipyridine, a benzeneboronic acid and a manganese salt |
| 04/01/2003 | US6541489 Excellent inhibitory activity of one or more matrix metalloprotease (MMP) enzymes, such as MMP-2, MMP-9, and MMP-13, while exhibiting substantially less inhibition at least of MMP- 1 |
| 04/01/2003 | US6541485 Urea substituted imidazoquinolines |
| 04/01/2003 | US6541482 Autoimmune disease |
| 04/01/2003 | US6541474 Administering a pharmaceutically effective dose of the heterocycle-containing carboxylic acid derivative or salt to a patient suffering form acute promyelocytic leukemia |
| 04/01/2003 | US6541469 CRF receptor antagonists and methods relating thereto |
| 04/01/2003 | US6541457 Mammalian IAP gene family, primers, probes and detection methods |
| 04/01/2003 | US6541040 Mixture consists of paraffins or synthetic waxes selected from montan waxes, petroleum waxes, Fischer-Tropsch waxes, polyolefin waxes, petrolatum waxes, wax alcohol and oxidates and atleast one alkali or alkaline hydroxide |
| 04/01/2003 | US6540978 Inhibitors of the bitter taste response |
| 04/01/2003 | CA2044676C Pharmaceutical composition for rectal administration of active principles exhibiting a prevalently topical medication action at the colon level |
| 03/28/2003 | WO2002030871A1 Use of amino acids for treating pain |
| 03/28/2003 | CA2424089A1 Use of amino acids for treating pain |
| 03/28/2003 | CA2405342A1 Methods of treatment and kits comprising a growth hormone secretagogue |
| 03/28/2003 | CA2404045A1 Use of coagulation factor vii-activating protease for the prophylaxis and therapy of vasoproliferative disorders |
| 03/27/2003 | WO2003025542A2 Immune response associated proteins |
| 03/27/2003 | WO2003025199A2 Mid 4460, a human tyrosine phosphatase family member and uses therefor |
| 03/27/2003 | WO2003025178A1 Novel protein and dna thereof |
| 03/27/2003 | WO2003025168A1 Novel protein and dna thereof |
| 03/27/2003 | WO2003025155A1 Fermentation product of cyptoporus volvatus and its preparation method and use |
| 03/27/2003 | WO2003025131A2 Protein modification and maintenance molecules |
| 03/27/2003 | WO2003025015A2 A soluble toll-like receptor |
| 03/27/2003 | WO2003025014A2 Use of peptides comprising post-translational modifications in the treatment of autoimmune pathologies |
| 03/27/2003 | WO2003024973A1 Spirocyclic-6,7-dihydro-5h-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines |
| 03/27/2003 | WO2003024971A1 6,7-dihydro-5h-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines |
| 03/27/2003 | WO2003024970A1 Compounds which inhibit the release of inflammatory cytokines |
| 03/27/2003 | WO2003024966A1 Pteridinone derivatives as modulators of chemokine receptor activity |
| 03/27/2003 | WO2003024965A2 Heterocyclic compounds that are inhibitors of the enzyme dpp-iv |
| 03/27/2003 | WO2003024957A1 Benzimidazole derivatives |
| 03/27/2003 | WO2003024953A1 Propanolamine derivative having 1,4-benzodioxane ring |
| 03/27/2003 | WO2003024948A1 Benzofuran and dihydrobenzofuran derivatives useful as beta-3 adrenoreceptor agonists |